Language Select
Varian Logo

Recent News

September 20, 2018
The phrase "You have cancer" understandably strikes fear into the hearts of millions of patients diagnosed with the disease every year around the world. But what if we lived in a world without the... Read more
September 12, 2018
Varian (NYSE: VAR) today announced that Jeffrey R. Balser, MD, PhD, president and chief executive officer at Vanderbilt University Medical Center and dean of Vanderbilt University School of... Read more
September 07, 2018
Varian (NYSE: VAR) signed a partnership agreement with Mediheal Group of Hospitals to expand access to radiotherapy in Kenya. This comprehensive partnership agreement includes the supply of... Read more

Recent Blog Posts

Sep 13, 2018 | Spot ON Blog
Stereotactic body radiation therapy (SBRT) is increasingly used as a result of its ability to spare healthy tissue, as well as for its enhanced tumor control and curative potential. Dr. Simone shares... Read more
Aug 17, 2018 | Centerline
At Sírio-Libanês Hospital in São Paulo, Brazil, patients are now starting radiation treatment on average two days sooner. Reducing the time from simulation to the first day of treatment is just one... Read more
Jul 10, 2018 | Centerline
Early adopters in the U.S., UK, and South Africa report that the Halcyon™ system, optimized for simplified and expedited image-guided IMRT and VMAT treatments, is living up to its promise of speed... Read more

Get News Releases by Email
Subscribe Now

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]